The phase III DUO trial of PI3K inhibitor duvelisib versus ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival - Danilov, Alexey V.; Flinn, Ian W.; Davids, Matthew S.; Gregory, Beth; Bentur, Ohad; Sidransky, David; Brown, Jennifer R. (Haematologica (Roma), 2024)